Proxalutamide shows promise as potential COVID-19 treatment

At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between androgen receptors-;which bind to hormones like testosterone–and SARS-CoV-2 viral infection.

Big PFS Improvement in Highly Mutated CRC With Dual Immunotherapy

SAN FRANCISCO — Frontline dual immunotherapy significantly improved progression-free survival (PFS) versus chemotherapy in microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) metastatic colorectal cancer (CRC),

January 23, 2024

Risk adjusted net present value: What is the current valuation of Bavarian Nordic’s PXVX-0317?

PXVX-0317 is a subunit vaccine commercialized by Bavarian Nordic, with a leading Phase III program in Chikungunya Fever.

November 20, 2023

Benefits and challenges of integrating nursing home residents into clinical trials

Clinical trials are constantly being designed and study participants enrolled to determine if medical treatments and therapies are safe and effective.

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.